Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wal-Mart expands generics program

Executive Summary

Wal-Mart is accelerating the roll-out of its discount generics program throughout Florida. The program, which was launched in the firm's Tampa-area outlets Sept. 21, provides 30-day supplies of certain generic products for $4 (1"The Pink Sheet" Oct. 2, 2006, p. 18). The firm had previously planned to launch the program statewide Jan. 1, 2007, but said it decided to advance the expansion due to strong demand. Wal-Mart reports 36,000 new prescriptions were filled in the Tampa stores in the first ten days after launch. Company also announces that the number of products included in the program has been expanded from 291 to 314...

You may also be interested in...

Wal-Mart Discount Drug Program Casts Shadow Over Generic Supply Chain

Wal-Mart's recent decision to offer a set, low price for a number of generic products could have significant negative business implications for the entire generic pharmaceutical supply chain

EMA Endorses Dexamethasone For COVID-19

Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.

'Covidization' Of Resources Brings Huge Disruption For TB Patients, Researchers

Redirection of healthcare resources to tackle COVID-19 is posing huge challenges for TB care and researchers in the area. Companies like J&J have stepped in to support, among other aspects, innovative community-based solutions to ensure continuity of care for drug resistant-TB patients amid the pandemic.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts